Form 4 for BDTX Black Diamond Therapeutics, Inc.
Accepted 2023-10-19 00:00:00 ET · period of report 2023-10-17 · accession 0000950170-23-054142 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-10-19 | 2023-10-17 | BDTX | BIOTECH GROWTH N V | 10% | P - Purchase | $2.34 | +400.0K | 8.52M | +5% | +$936.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-10-17 | P | A | 400,000 | $2.34 | 8,517,839 | D | — | — |